This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sarah Ashby Promoted To VP And General Counsel At Psychemedics Corporation

ACTON, Mass., May 14, 2013 /PRNewswire/ -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair analysis drug testing, today announced that Sarah Ashby has been promoted to the position of Vice President and General Counsel.

(Logo: http://photos.prnewswire.com/prnh/20111107/NE00639LOGO )

In this role, Sarah is responsible for directing and managing all of the company's legal activities and reports to the company's CEO. Sarah joined Psychemedics in April 2012 as Associate General Counsel after 10 years in private practice focusing on civil litigation, FDA regulation and government investigations.    

In making the announcement, Raymond C. Kubacki, Chairman and CEO of Psychemedics stated, "Sarah has been an outstanding addition to our team at Psychemedics. Over the past year, she has worked diligently on numerous legal matters and has clearly demonstrated her ability and strong work ethic. She has won the confidence of the other members of our management team, and there is no question she is ready to take the next step in becoming Vice President and General Counsel."

About Psychemedics Psychemedics (NASDAQ: PMD) is the world's leading drug testing company using hair for the detection of drugs of abuse. Psychemedics has been successfully operating for 25 years and thousands of corporations worldwide currently rely on Psychemedics' patented hair analysis technology for their pre-employment and employee drug screening. Psychemedics' clients include over 10% of the Fortune 500, some of the largest police departments in America, six Federal Reserve Banks, and schools. For more information, visit the Psychemedics website at www.psychemedics.com .

Contact: Raymond C. KubackiChairman & CEO(978) 206-8220 RayK@psychemedics.com

SOURCE Psychemedics Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs